Диссертация (Современные подходы к оптимизации использования противомикробных средств в условиях многопрофильного стационара), страница 48

– 1995. – Vol. 7, № 2. – P. 128-140.257.Goldstein, D. J. The need for clinical pharmacology is greater than ever / D.J. Goldstein, P. K. Honig, S. Spielberg // Clin. Pharmacol. Ther. – 2008. – Vol. 83.– P. 213-217.258.Gould, L. M. A review of the role of antibiotic policies in the control ofantibiotic resistance // L. M.

Gould // Antimicrob. Chemother. – 1999. – Vol. 43,№ 4. – P. 459-465.259.Gould, L. M. Stewardship of antibiotic use and resistance surveillance: theinternational scene // L. M. Gould // Hosp. Inf. – 1999. – Vol. 43, suppl. – S. 253S260.260.Haley, R. W. The efficacy of infection surveillance and control programs inpreventing nosocomial infections in US hospitals / R. W Haley// Am. J.Epidemiol. – 1985. – Vol. 121. – P. 182-205.261.Harbarth, S. Universal screening for methicillin-resistant Staphylococcusaureus at hospital admission and nosocomial infection in surgical patients / S.Harbarth // JAMA.

– 2008. – Vol. 299. – P. 1149-1157.262.Holmberg, S. D. Health and economic impacts of antimicrobial resistance /S. D. Holmberg, S. L. Solomon, P. A. Blake // Rev. Infect. Dis. – 1987. – Vol. 9,№ 6. – P. 1065-1078.263.Horan, T. C. CDC/NHSN surveillance definition of health care-associatedinfection and criteria for specific types of infections in the acute care setting / T. C.Horan, M. Andrus, M. A.

Dudeck // Am. J. Infect. Control. – 2008. – № 36. – P.309-332.264.Hughes, J. M. Study on the efficacy of nosocomial infection control (SENICProject): results and implications for the future / J. M. Hughes // Chemotherapy. –1988. – Vol. 34.

– P. 553-561.312265.Hughes, W. T. 1997 guidelines for the use of antimicrobial agents inneutropenic patients with unexplained fever. Infectious Diseases Society ofAmerica / W. T. Hughes // Clin. Infect. Dis. – 1997. – Vol. 25. – P. 551-573.266.Inadequate antimicrobial treatment of infections: a risk factor for hospitalmortality among critically ill patients / M. H.

Kollef [et al.] // Chest. – 1999. – Vol.115, № 2. – P. 462-474.267.Incidence rate and variable cost of nosocomial infections in different typesof intensive care units / Y. Y. Chen [et al.] // Infect. Control Hosp. Epidemiol. –2009. – Vol. 30. – P. 39-46.268.Joint Commission. National patient safety goals. The Joint Commission,OakbrookTerrace,IL.2010[Electronicresousce].–Accessmode:http://www.jointcommission.org/patientsafety/nationalpatientsafetygoals/.–[Access date 21.06.2016].269.Kampf, G. Efficacy of three ethanol-based hand rubs against felinecalicivirus, a surrogate virus for norovirus / G. Kampf, D. Grotheer, J. Steinmann //J.

Hosp. Infect. – 2005. – Vol. 60. – P. 144-149.270.Lomas, J. Words without action? The production, dissemination and impactof consensus recommendations / J. Lomas // Ann. Rev. Public Health. – 1999. –Vol. 19. – P. 41-65.271.Lucet, J. C. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units / J. C. Lucet // IntensiveCare Med.

– 2005. – Vol. 31. – P. 1051-1057.272.Making health care safer: a critical analysis of patient safety practices / K.G. Shojania [et al.] // Evid. Rep. Technol. Assess. (Summ.). – 2001. –P. 1-668.273.Miller, G. Responding to simulated pandemic influenza in San Antonio,Texas / G. Miller, S. Randolph, J. E.

Patterson // Infect. Control Hosp. Epidemiol.– 2008. – Vol. 29. – P. 320-326.313274.Munoz-Price, L. S. Long-term acute care hospitals / L. S. Munoz-Price //Clin. Infect. Dis. – 2009. – Vol. 49. – P. 438-443.275.National and State Healthcare-Associated Infections Progress Report (HAIProgress Report), USA, (2014 data, published 2016) [Electronic resource]. –Access mode: http://www.cdc.gov/hai/surveillance/. – [Access date: 15.06.2016].276.Nosocomial infection in elderly patients in the United States 1986-1990 /T.C. Emori [et al.] // Amer. J.

Med. – 1991. – Vol. 91, suppl. 3B. – P. 289-293.277.Nosocomial infection rates in adult and pediatric intensive care units in theUnited States / W. P. Jarvis [et al.] // Amer. J. Med. – 1991. – Vol. 91, suppl. 3B. –P. 185-191.278.Nosocomial infection rates in the General Surgery Department of theTeaching Hospital Gabriel Toure in Bamako, Mali Togo A. / A. Nautiyal [et al.] //Carib. J. SciTech.

– 2015. – Vol. 3. – Р. 781-788.279.Nosocomial infections in intensive care wards: A multicenter prospectivestudy / F. D. Dashner [et al.] // Intens. Care Med. – 1982. – Vol. 8. – P. 5-9.280.O'Malley, C. A. Infection control in cystic fibrosis: cohorting, cross-contamination, and the respiratory therapist / C. A. O'Malley // Respir. Care. –2009. – Vol. 54. – P. 641-657.281.Orange book 2015 [Electronic resourse].

– 35th ed. – Access mode:www.accessdata.fda.gov/scripts/cder/ob/eclink.cfm. – [Access date: 15.06.2016].282.Patel, D. How to make antimicrobial stewardship work: practicalconsiderations for hospitals of all sizes / D. Patel, C. MacDougall // Hosp. Pharm.– 2010. – Vol. 45, suppl.1. – P. S10-S18.283.Petrosillo, N. Nosocomial infections in HIV infected patients.

Gruppo HIV eInfezioni Ospedaliere / N. Petrosillo // AIDS. – 1999. – Vol. 13. – P. 599-605.284.Pittet, D. Effectiveness of a hospital-wide programme to improvecompliance with hand hygiene. Infection Control Programme / D. Pittet // Lancet.– 2000. – Vol. 356. – P. 1307-1312.314285.Preston, G. A. Effect of private isolation rooms on patient care practices:colonization and infection in an intensive care unit / G. A.

Preston, E. L. Larson,W. E. Stamm // Amer. J. Med. –1981. – Vol. 70. – P. 641-645.286.Pronovost, P. An intervention to decrease catheter-related bloodstreaminfections in the ICU / P. Pronovost // N. Engl. J. Med. – 2006. – Vol. 355. – P.2725-2732.287.Reffel, J. A. Generic antiarrhythmic are not therapeutically equivalent forthe treatment of rachyarrhythyhmia / J. A. Reffel, P. R. Kowey // Am. J. Cardiol. –2000. – Vol. 85.

– P. 1151-1153.288.Reidenberg, M. Clinical pharmacology: the scientific basis of therapeutics /M. Reidenberg // Clin. Pharmacol. Ther. – 1999. – Vol. 66, № 1. – P. 2-8.289.Robicsek, A. Universal surveillance for methicillin-resistant Staphylococcusaureus in 3 affiliated hospitals / A. Robicsek // Ann. Intern. Med. – 2008.

– Vol.148. – P. 409-418.290.Rolain, J. M. New Delhi metallo-beta-lactamase (NDM-1): towards a newpandemia? / J. M Rolain, P. Parola, G. Cornaglia // Clin. Microbiol. Infect. – 2010.– Vol. 15, suppl. 2. – P. 98-99.291.Rosenthal, V.

D. Nosocomial infections in medical-surgical intensive careunits in Argentina: attributable mortality and length of stay / V. D. Rosenthal, S.Guzman, P. W. Orellano // AJIC. – 2003. – Vol. 31, № 5. – P. 291-295.292.Salgado, C. D. What proportion of hospital patients colonized withmethicillin-resistantStaphylococcusaureusareidentifiedbyclinicalmicrobiological cultures? / C. D. Salgado, B. M. Farr // Infect. Control Hosp.Epidemiol. – 2006. – Vol.

27. – P. 116-121.293.Shelley, F. Paul Mqrtini: the first clinical pharmacologist? / F. Shelley, M.Baur // Lancet. – 1999. – Vol. 353. – P. 1870-1873.294.Sjoqvist, F. The past, present and future of clinical pharmacology / F.Sjoqvist // Eur. J. Clin. Pharmacol. – 1999.

– Vol. 55. – Р. 553-557.315295.Smith-Moland, E. S. Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates / E. S. Smith-Moland // J.Antimicrob. Chemother. – 2003. – Vol. 51. – P. 711-714.296.Stone, P. W. Systematic review of economic analyses of health care-associated infections // P. W. Stone, D. Brassia, E. Lorson // Am. J. Infect. Control.– 2005. – Vol. 33. – P. 501-509.297.Strausbaugh, L.

J. Preventing transmission of multidrug-resistant bacteria inhealth care settings: a tale of 2 guidelines / L. J. Strausbaugh, J. D. Siegel, R. AWeinstein // Clin. Infect. Dis. – 2006. – Vol. 42. – P. 828-835.298.Stroud, L. Nosocomial infections in HIV-infected patients: preliminaryresults from a multicenter surveillance system (1989-1995) / L. Stroud // Infect.Control Hosp. Epidemiol.

– 1997. – Vol. 18. – P. 479-485.299.Surveillance for nosocomial infections and fever of unknown origin amongadult hematology-oncology patients / S. Engelhart [et al.] // Infect. Control Hosp.Epidemiol. – 2002. – Vol. 23. – P. 244-248.300.Sydnor, E. R. Hospital epidemiology and infection control in acute-caresettings / E. R. Sydnor, T. M. Perl // Microbiol.

Rev. – 2011. – Vol. 24, № 1. – P.141-173.301.Taylor, M. E. Hospital-acquired infection in elderly patients / M. E. Taylor,B. A. Oppenheim // J. Hosp. Infect. – 1998. – Vol. 38. – P. 245-260.302.The SENIC Project. Study on the efficacy of nozocomial infection control(SENIC Project). Summary of study design / R. W. Haley [et al.] // Am. J.Epidemiol. – 1980. – V. 111. – P. 472-485.303.Topical therapy for methicillin-resistant Staphylococcus aureus colonization:impact on infection risk / A.

Robicsek [et al.] / Infect. Control Hosp. Epidemiol. –2009. – Vol. 30. – P. 623-632.304.Vincent, J. L. Nosocomial infections in adult intensive-care units / J. L.Vincent // Lancet. – 2003. – Vol. 361, № 9374. – P. 2068-77.316305.Weber, S. G. Legislative mandates for use of active surveillance cultures toscreen for methicillin-resistant Staphylococcus aureus and vancomycin-resistantenterococci: position statement from the Joint SHEA and APIC Task Force / S. G.Weber // Infect.

Control Hosp. Epidemiol. –2007. – Vol. 28. – P. 249-260.306.Wong, E. S. Public disclosure of healthcare-associated infections: the role ofthe Society for Healthcare Epidemiology of America / E. S. Wong // Infect.Control Hosp. Epidemiol. – 2005. – Vol. 26. – P. 210-212.307.Yokoe, D. S. Improving patient safety through infection control: a newhealthcare imperative / D. S. Yokoe, D. Classen // Infect. Control Hosp.Epidemiol.

– 2008. – Vol. 29, suppl. 1. – P. S3-S11.308.Yuk, J. H. Clinical pharmacocinetics of ceftriaxone / J. H. Yuk, C. H.Nightingale, R. Quintiliani // Clin. Pharmacocinetics. – 1989. – Vol. 17, № 4. – P.223-235..